Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study
Authors:
- R. BrettleRBR. Brettle
- O. KirkOKO. Kirk
- A. BlaxhultABA. Blaxhult
- J. M. ParkinJPJ. M. Parkin
- F. AntunesF. Antunes
- P. FrancioliPFP. Francioli
- A. D'Arminio MonforteAMA. D'Arminio Monforte
- Z. FoxZFZ. Fox
- J. D. LundgrenJLJ. D. Lundgren
- 1 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (12) , 1663-1671
Abstract
The causes of death among HIV-positive patients may have changed since the introduction of highly active antiretroviral therapy (HAART). We investigated these changes, patients who died without an AIDS diagnosis and factors relating to pre-AIDS deaths. Analyses of 1826 deaths among EuroSIDA patients, an observational study of 8556 patients. Incidence rates of pre-AIDS deaths were compared to overall rates. Factors relating to pre-AIDS deaths were identified using Cox regression. Death rates declined from 15.6 to 2.7 per 100 person-years of follow-up (PYFU) between 1994 and 2001. Pre-AIDS incidence declined from 2.4 to 1.1 per 100 PYFU. The ratio of overall to pre-AIDS deaths peaked in 1996 at 8.4 and dropped to < 3 after 1998. The adjusted odds of dying following one AIDS defining event (ADE) increased yearly (odds ratio, 1.53;P < 0.001), conversely the odds of dying following three or more ADE decreased yearly (odds ratio, 0.79;P < 0.001). The proportion of deaths that followed an HIV-related disease decreased by 23% annually; in contrast there was a 32% yearly increase in the proportion of deaths due to known causes other than HIV-related or suicides. Injecting drug users (IDU) were significantly more likely to die before an ADE than homosexuals (relative hazard, 2.97;P < 0.0001) and patients from northern/eastern Europe (relative hazard, 2.01;P < 0.0001) were more likely to die pre-AIDS than southern patients. The proportion of pre-AIDS deaths increased from 1994 to 2001; however, the incidence of pre-AIDS deaths and deaths overall declined. IDU and subjects from northern/eastern Europe had an increased risk of pre-AIDS death. HIV-positive patients live longer therefore it is essential to continue to monitor all causes of mortality to identify changes.Keywords
This publication has 28 references indexed in Scilit:
- Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual menAIDS, 2000
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Severe premature coronary artery disease with protease inhibitorsThe Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Pre-AIDS mortality from natural causes associated with HIV disease progressionAIDS, 1997
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Pre-AIDS deaths in HIV infection related to intravenous drug useQJM: An International Journal of Medicine, 1997
- Clinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992